(0.26%) 5 145.00 points
(0.27%) 38 544 points
(0.37%) 17 911 points
(-0.80%) $83.18
(1.30%) $1.948
(-0.13%) $2 344.20
(1.20%) $27.58
(0.69%) $928.50
(-0.28%) $0.932
(-0.24%) $11.00
(-0.40%) $0.797
(0.85%) $92.65
Live Chart Being Loaded With Signals
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally...
Stats | |
---|---|
本日の出来高 | 436 657 |
平均出来高 | 1.71M |
時価総額 | 6.50M |
EPS | $0 ( 2024-04-03 ) |
次の収益日 | ( $-0.0900 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0800 |
ATR14 | $0.00500 (0.98%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-23 | Lazar David E. | Buy | 150 000 | Series E Convertible Preferred Stock |
2024-04-11 | Ben-tzvi Avraham | Buy | 100 000 | Common Stock |
2024-04-11 | Natan David | Buy | 100 000 | Common Stock |
2024-04-11 | Mcmurdo Matthew Charles | Buy | 100 000 | Common Stock |
2024-04-11 | Lazar David E. | Buy | 100 000 | Common Stock |
INSIDER POWER |
---|
-71.10 |
Last 97 transactions |
Buy: 3 573 408 | Sell: 6 921 404 |
ボリューム 相関
OpGen Inc 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
OpGen Inc 相関 - 通貨/商品
OpGen Inc 財務諸表
Annual | 2022 |
収益: | $2.61M |
総利益: | $-816 698 (-31.32 %) |
EPS: | $-15.05 |
FY | 2022 |
収益: | $2.61M |
総利益: | $-816 698 (-31.32 %) |
EPS: | $-15.05 |
FY | 2021 |
収益: | $4.31M |
総利益: | $1.46M (33.85 %) |
EPS: | $-2.20 |
FY | 2020 |
収益: | $4.21M |
総利益: | $365 950 (8.68 %) |
EPS: | $-1.660 |
Financial Reports:
No articles found.
OpGen Inc
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。